There are 2137 resources available
486P - Genetic polymorphism profile associated with cetuximab efficiency in colorectal cancer patients from Kazakhstan
Presenter: Irina Kadyrova
Session: E-Poster Display
Resources:
Abstract
487P - Use of patient-derived tumour organoids to identify acquired treatment resistance and determine optimal post-progression combinations in metastatic colorectal cancer
Presenter: Giulia Martini
Session: E-Poster Display
Resources:
Abstract
488P - Patient-derived organoids as a tool for modelling localized colorectal cancer
Presenter: Maria Fernanda Gutierrez Bravo
Session: E-Poster Display
Resources:
Abstract
489P - Somatic mosaic model of colorectal cancer for translational immune cancer research
Presenter: Stefania Napolitano
Session: E-Poster Display
Resources:
Abstract
490P - Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor
Presenter: Federica Papaccio
Session: E-Poster Display
Resources:
Abstract
491P - Neoadjuvant nivolumab in early stage colorectal cancer
Presenter: Antonio Avallone
Session: E-Poster Display
Resources:
Abstract
492P - A multicenter LArge retrospectIve daTabase on the personalization of Stereotactic ABlative Radiotherapy for lung metastases from colorectal cancer: Early results from the LaIT-SABR study
Presenter: Luca Nicosia
Session: E-Poster Display
Resources:
Abstract
493P - Pembrolizumab (pembro) plus mFOLFOX7 or FOLFIRI in patients (pts) with metastatic colorectal cancer (mCRC): Updated results from KEYNOTE-651 cohorts B and D
Presenter: Richard Kim
Session: E-Poster Display
Resources:
Abstract
495P - Lack of liver metastases identifies a group of MSS metastatic colorectal cancer with potential benefit from PD-1/PD-L1 targeting
Presenter: Marwan Fakih
Session: E-Poster Display
Resources:
Abstract
496P - Factors associated with colorectal cancer in patients 18 to 50 years old in the United States
Presenter: Yull Arriaga
Session: E-Poster Display
Resources:
Abstract